Sentences with phrase «in tumor immunology»

She received the William B. Coley Award for Distinguished Research in Tumor immunology in 2014 for her contributions to the discovery of PD - 1 pathway.

Fascinated by human immunology and translational research, I undertook my PhD in tumor immunology at the University of Tuebingen (Germany).

He received the William B. Coley Award for Distinguished Research in Tumor Immunology in 2014 and the Laguna Biotech CEO Forum award for his contributions to the discovery of the PD - 1 pathway.

The Clinical Accelerator network includes approximately 80 of the world's leading physician - scientists with expertise in tumor immunology and cancer immunotherapy clinical trials, immune monitoring, and correlative research.

Fascinated by the concept of cancer vaccines, I undertook my PhD in tumor immunology jointly at the University of Southampton (Ottensmeier Lab) and University of California, San Francisco (Coussens Lab).

The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.

She trained in tumor immunology as a senior clinical and research fellow before joining the faculty at Johns Hopkins University in 2001.

«Immunotherapy in Renal Carcinoma, in Advances in Tumor Immunology and Immunotherapy.

CRI Scientific Advisory Council director Lloyd J. Old, M.D., a pioneer responsible for many seminal discoveries in the field, is a senior expert in tumor immunology who for the past four decades has guided the scientific vision for CRI and who currently leads the Institute's global cancer vaccine research programs.

Following graduation, performed research and received a M.S. in tumor immunology at Roswell Park Cancer Institute in Buffalo, NY in 2012.

He received the 2014 William B. Coley Award for Distinguished Research in Tumor Immunology and the 2017 Warren Alpert Foundation award for this work, which led to development of the PD - 1 pathway blockade for cancer immunotherapy.

iTeos Therapeutics is leveraging its expertise in tumor immunology, translational medicine and drug discovery to deliver the next wave of immune therapies for the treatment of inflamed (hot) and non-inflamed (cold) tumors.

Dr. Sadelain is the recipient of the Cancer Research Institute's William B. Coley Award for Distinguished Research in Tumor Immunology, the Sultan Bin Khalifa International Award for Innovative Medical Research on Thalassemia, and the New York Intellectual Property Law Association Inventor of the Year Award.

At the dinner, the Cancer Research Institute will also celebrate excellence in scientific research with presentations of the 2017 William B. Coley Award for Distinguished Research in Basic Immunology to Rafi Ahmed, Ph.D., of Emory University, and the 2017 William B. Coley Award for Distinguished Research in Tumor Immunology to Thomas F. Gajewski, M.D., Ph.D., of the University of Chicago.

Although he had never conducted research in tumor immunology, in 1979 Steinman submitted an application to the Cancer Research Institute for a pilot grant to explore this novel hypothesis.

Bryan Choi, the recipient of a Student Training and Research in Tumor Immunology (STaRT) grant at Duke University, is working to develop a new strategy using Bispecific T cell Engagers (BiTEs) to treat glioblastoma.